追踪和减少艾滋病毒/艾滋病患者退伍军人的酒精消费 (TRAC) 干预:来自试点随机等候名单控制试验的结果
Carolyn Lauckner1, Reuben Adatorwovor2, Erica Taylor3
1C.S. Mott Department of Public Health, Michigan State University, 200 East 1st St, Flint, MI, 48502, USA. clauck@msu.edu.
Addiction science & clinical practice
|December 3, 2025
概括
TRAC移动干预计划显示,它有望减少艾滋病毒/艾滋病 (VWH) 的退伍军人滥用酒精. 观察到高可行性和可接受性,初步证据表明减少饮酒和改善ART坚持.
科学领域:
- 公共卫生 公共卫生
- 行为科学 行为科学
- 数字健康干预措施 数字健康干预措施
背景情况:
- 患有艾滋病毒/艾滋病的退伍军人 (VWH) 经常与滥用酒精作斗争,这会对治疗的坚持和健康结果产生负面影响.
- TRAC (跟踪和减少酒精消费) 的干预措施是为了解决VWH的酒精使用问题而开发的.
- TRAC利用移动技术为酒精和ART使用提供咨询和日常监测.
研究的目的:
- 评估VWH中TRAC干预的可行性和可接受性.
- 评估TRAC对酒精使用和ART坚持的初步影响.
主要方法:
- 一个试点随机等候名单受控试验,50名VWH参与者.
- 干预组立即接受了TRAC;对照组在8周后接受了它.
- 在24周内收集了有关干预评级,酒精使用,ART坚持和自我有效性的数据.
主要成果:
- 高可行性和可接受性:84%的保留率,高的会议评分 (9.6/10),以及调查和呼吸计读数的高完成率.
- 在干预组中,饮酒过度减少和错过的ART剂量减少的趋势.
- 聚合数据分析表明,TRAC与饮酒相关结果的减少有关.
结论:
- 对于VWH来说,TRAC的干预是非常可行的和可以接受的.
- 初步证据表明,TRAC可能会减少酒精使用并改善ART的坚持.
- 需要在更大的随机对照试验中进行进一步评估,以确认疗效.
更多相关视频
05:12Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
1.4K
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
10.1K
相关概念视频
Community Based Intervention
260
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
260
Therapeutic Drug Monitoring: Affecting Factors
182
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
182
